Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology

COVID-19 caused by the SARS-CoV-2 virus is widespread in all regions, and it disturbs host immune system functioning leading to extreme inflammatory reaction and hyperactivation of the immune response. Kabasura Kudineer (KSK) is preventive medicine against viral infections and a potent immune booster for inflammation-related diseases. We hypothesize that KSK and KSK similar plant compounds, might prevent or control the COVID-19 infection in the human body. 1,207 KSK and KSK similar compounds were listed and screened via the Swiss ADME tool and PAINS Remover; 303 compounds were filtered including active and similar drug compounds. The targets were retrieved from similar drugs of the active compounds of KSK. Finally, 573 genes were listed after several screening steps. Next, network analysis was performed to finalize the potential target gene: construction of protein-protein interaction of 573 genes using STRING, identifying top hub genes in Cytoscape plug-ins (MCODE and cytoHubba). These ten hub genes play a crucial role in the inflammatory response. Target-miRNA interaction was also constructed using the miRNet tool to interpret miRNAs of the target genes and their functions. Functional annotation was done via DAVID to gain a complete insight into the mechanism of the enriched pathways and other diseases related to the given target genes. In Molecular Docking analysis, IL10 attained top rank in Target-miRNA interaction and also the gene formed prominent exchanges with an excellent binding score (> = -8.0) against 19 compounds. Among them, Guggulsterone has an acute affinity score of -8.8 for IL10 and exhibits anti-inflammatory and immunomodulatory properties. Molecular Dynamics simulation study also performed for IL10 and the interacting ligand compounds using GROMACS. Finally, Guggulsterone will be recommended to enhance immunity against several inflammatory diseases, including COVID19.

[1]  Md. Abdullah Aziz,et al.  In Silico Analysis and Experimental Evaluation of Ester Prodrugs of Ketoprofen for Oral Delivery: With a View to Reduce Toxicity , 2021, Processes.

[2]  A. Kallianos,et al.  Visceral leishmaniasis and COVID-19 coinfection – A case report , 2021, IDCases.

[3]  Svenia P. Jose,et al.  Anti-inflammatory effect of Kaba Sura Kudineer (AYUSH approved COVID-19 drug)-A Siddha poly-herbal formulation against lipopolysaccharide induced inflammatory response in RAW-264.7 macrophages cells , 2021, Journal of Ethnopharmacology.

[4]  Zhiyi Zhou,et al.  Network pharmacology and molecular docking study on the mechanism of colorectal cancer treatment using Xiao-Chai-Hu-Tang , 2021, PloS one.

[5]  H. Taha,et al.  Bioactive Phytoconstituents of Morus Plants exhibiting Numerous Therapeutic Activities , 2021 .

[6]  Muhammet Fatih Aydin,et al.  Ulcerative Colitis in a COVID-19 Patient: A Case Report. , 2021, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[7]  Dhivya Dhanasekaran,et al.  Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect , 2021, Obesity Medicine.

[8]  Nasir Afsar,et al.  COVID-19: An Emerging Culprit of Inflammatory Arthritis , 2021, Case reports in rheumatology.

[9]  K. G. Divya,et al.  Pharmacological Actions of Contents of Kabasura Kudineer: A Siddha Formulation for Fever with Respiratory Illness , 2021 .

[10]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[11]  Li Yang,et al.  COVID-19: immunopathogenesis and Immunotherapeutics , 2020, Signal Transduction and Targeted Therapy.

[12]  S. Rehman,et al.  Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review , 2020, Journal of medical Internet research.

[13]  Md. Abdus Shahid,et al.  Immune response in COVID-19: A review , 2020, Journal of Infection and Public Health.

[14]  Maciej Banach,et al.  Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper , 2020, Frontiers in Immunology.

[15]  B. Vincenzi,et al.  COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management , 2020, Expert opinion on biological therapy.

[16]  D. Ragab,et al.  The COVID-19 Cytokine Storm; What We Know So Far , 2020, Frontiers in Immunology.

[17]  J. Xia,et al.  miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology , 2020, Nucleic Acids Res..

[18]  H. Niazkar,et al.  The neurological manifestations of COVID-19: a review article , 2020, Neurological Sciences.

[19]  Charles C. N. Wang,et al.  Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis , 2020, Frontiers in Oncology.

[20]  S. Ghasemi,et al.  Genotype and phenotype of COVID-19: Their roles in pathogenesis , 2020, Journal of Microbiology, Immunology and Infection.

[21]  T. Velavan,et al.  The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.

[22]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[23]  Feng Zhu,et al.  Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics , 2019, Nucleic Acids Res..

[24]  Barry Demchak,et al.  Cytoscape Automation: empowering workflow-based network analysis , 2019, Genome Biology.

[25]  U. Coffeen,et al.  Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action , 2019, Journal of pain research.

[26]  Thomas Gaillard,et al.  Evaluation of AutoDock and AutoDock Vina on the CASF-2013 Benchmark , 2018, J. Chem. Inf. Model..

[27]  Hans-Peter Lenhof,et al.  About miRNAs, miRNA seeds, target genes and target pathways , 2017, Oncotarget.

[28]  R. P. Vivek-Ananth,et al.  IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics , 2017, bioRxiv.

[29]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[30]  K. Sargsyan,et al.  Preferred Hydrogen-Bonding Partners of Cysteine: Implications for Regulating Cys Functions. , 2016, The journal of physical chemistry. B.

[31]  Yifeng Chai,et al.  Drug target identification using network analysis: Taking active components in Sini decoction as an example , 2016, Scientific Reports.

[32]  N. Oezguen,et al.  Regulation of protein-ligand binding affinity by hydrogen bond pairing , 2016, Science Advances.

[33]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[34]  Michael Schroeder,et al.  PLIP: fully automated protein–ligand interaction profiler , 2015, Nucleic Acids Res..

[35]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[36]  Sung-Dae Cho,et al.  24-hydroxyursolic acid from the leaves of the Diospyros kaki (Persimmon) induces apoptosis by activation of AMP-activated protein kinase. , 2010, Planta medica.

[37]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[38]  Alexander D. MacKerell,et al.  CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields , 2009, J. Comput. Chem..

[39]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[40]  S. Mahboobi,et al.  Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones. , 2007, Bioorganic & medicinal chemistry.

[41]  Raymond P Donnelly,et al.  Conformational Changes Mediate Interleukin-10 Receptor 2 (IL-10R2) Binding to IL-10 and Assembly of the Signaling Complex* , 2006, Journal of Biological Chemistry.

[42]  M K Chelbi-Alix,et al.  Arsenic enhances the apoptosis induced by interferon gamma: key role of IRF-1. , 2006, Cellular and molecular biology.

[43]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[44]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[45]  A. Zehnder,et al.  Chemical properties of catechols and their molecular modes of toxic action in cells, from microorganisms to mammals. , 2001, Environmental microbiology.

[46]  J L Sussman,et al.  Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. , 1998, Acta crystallographica. Section D, Biological crystallography.

[47]  A. D. Hunter.  ACD/ChemSketch 1.0 (freeware); ACD/ChemSketch 2.0 and its Tautomers, Dictionary, and 3D Plug-ins; ACD/HNMR 2.0; ACD/CNMR 2.0 , 1997 .

[48]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[49]  K. Tanaka,et al.  Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma , 1996, The Journal of experimental medicine.

[50]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[51]  K. Frei,et al.  Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. , 1994, Journal of immunology.

[52]  K. Arai,et al.  Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[53]  L. Mitscher,et al.  Alkaloids of Thalictrum. XV. Isolation and identification of the hypotensive alkaloids of the root of Thalictrum lucidum. , 1976, Lloydia.